The First Saint Petersburg Regional Inflammatory Bowel Diseases Registry on the Basis of the Regional Health Information System: Principles of Functioning, Testing Results, Plan of Development

Aim: to present the principles of functioning of the regional registry of inflammatory bowel disease (IBD) patients in Saint Petersburg on the basis of the City Health Information System (Saint Petersburg IBD Registry).

Key points. The Saint Petersburg IBD Registry consists of General Statistical Module and Clinical Module. The General Statistical Module is intended to analyze the prevalence of ulcerative colitis and Crohn's disease, the number of patient visits to medical institutions; to assess the burden on the healthcare system, demographic characteristics, routing and mortality for the whole region. The Clinical Module allows to assess the IBD features in prospective observation. The register case report form is integrated into the patient's status in the Medical Information System of the medical institution. Saint Petersburg IBD Registry operates on the basis of the Saint Petersburg Medical Center of Information and Analysis within the framework of the Regional Medical Data Collection System of the Russian state information system “Regional Fragment of the Unified State Information System in the Healthcare Branch”. The accumulation of prospective data in the Clinical Module continues, which in the near future will make it possible to test and configure the automated analytical block of the registry.

Conclusion. The functioning of the Saint Petersburg IBD Registry allows to achieve following primary goals within region: assessment of the epidemiological features of IBD in Saint Petersburg; dynamic assessment of the disease features; assessment and planning of health care resources required to provide care to IBD patients; improvement of approaches to the treatment taking into account the specifics of the region; assessment of the effectiveness and tolerability of specific treatment including biologics.

1. Ivashkin V.T., Shelygin Y.A., Abdulganieva D.I., Abdulhakov R.A., Alekseeva O.P., Alekseenko S.A. et al. Clinical recommendations for the diagnosis and treatment of Crohn's disease in adults (project). Coloproctology. 2020;19(2):8-38. https://doi.org/10.33878/2073-7556-2020-19-2-8-38 (in Russ.).

2. Ivashkin V.T., Shelygin Yu.A., Belousova E.A., Abdulganieva D.I., Alekseeva O.P., Achkasov S.I. et al. Draft clinical guidelines for the diagnosis and treatment of ulcerative colitis. Coloproctology. 2019;18(4):7-36. https://doi.org/10.33878/2073-7556-2019-18-4-7-36 (in Russ.).

3. Shchukina O.B. Ivanov S.V., Shotik A.V. Practical recommendations for therapists on the diagnosis and treatment of ulcerative colitis. University Therapeutic Journal. 2021;1:58-70 (in Russ.).

4. Shchukina O.B. Ivanov S.V., Shotik A.V. Practical recommendations for therapists on the diagnosis and treatment of Crohn’s disease. University Therapeutic Journal. 2021;1:71-85 (in Russ.).

5. Brooke E.M. The Current and Future Use of Registers in Health Information Systems. Geneva, Switzerland: World Health Organization; 1974. Publication No. 8.

6. Bernstein C.N. Large Registry Epidemiology in IBD. Inflamm Bowel Dis. 2017;23(11):1941-1949. https://doi.org/10.1097/MIB.0000000000001279.

7. Osipenko M.F., Valuyskikh E.Yu., Svetlova I.O. Kulygina Yu.A., Kalinskaya M.I., Bikbulatova E.A. et al. The importance of the register of inflammatory bowel diseases for assessing the quality of therapeutic and diagnostic measures. Experimental and clinical gastroenterology. 2016;9 (133): 42-47 (in Russ.).

8. Yagudina R.I., Litvinenko M.M., Sorokovikov I.V. Patient registers: structure, functions, possibilities of use. Pharmacoeconomics. 2011; 4(4):3-7.

9. Long M.D., Kappelman M.D., Martin C.F., Lewis J.D., Mayer L., Kinneer P.M. et al. Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results. Inflamm Bowel Dis. 2012;18:2099-2106.

10. Ekbom A., Helmick C., Zack M. Adami H.O. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323:1228-1233. https://doi.org/10.1056/NEJM199011013231802.

11. Andersen N.N, Pasternak B., Friis-Møller N., Andersson M., Jess T. Association between tumour necrosis factor-a inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study. BMJ. 2015;350:h2809. https://doi.org/10.1136/bmj.h2809.

12. Sperger J., Shah K.S., Lu M., Zhang X., Ungaro R.C., Brenner E.J. et. al. Development and validation of multivariable prediction models for adverse COVID-19 outcomes in patients with IBD. BMJ Open. 2021;11(11):e049740. https://doi.org/10.1136/bmjopen-2021-049740.

13. Belousova E.A., Abdulganieva D.I., Alekseeva O.P., Alekseenko S.A., Baranovsky A.Yu., Valuyskikh E.Yuet al. Social-demographic characteristics, current features and treatment options for inflammatory bowel diseases in Russia. The results of two multicenter studies. Almanac of Clinical Medicine. 2018;46(5):445-463. https://doi.org/10.18786/2072-0505-2018-46-5-445-463 (In Russ.).

14. Gubonina I.V., Grinevich V.B., Tkachenko E.I., Volga N.B., Sharap O.S., Poluektov M.V. et al. Clinical and epidemiological characteristics and outcomes of inflammatory bowel diseases in a cohort of patients in the North-West region according to eight-year observation. Experimental and clinical gastroenterology. 2019;12(172):24-33. https://doi.org/10.31146/1682-8658-ecg-172-12-24-33 (in Russ.).

15. Bakulin I.G., Kalinskaya M.I., Tellaeva E.V. North-Western register of patients with inflammatory bowel diseases: achievements and lessons. Coloproctology. 2022;21(1):37-49. https://doi.org/10.33878/2073-7556-2022-21-1-37-49 (in Russ.).

16. Bakulin I.G., Zhigalova T.N., Lataria E.L., Tellaeva E.V., Kalinskaya M.I., Sitkin S.I. et al. Experience in the implementation of the federal register of patients with inflammatory bowel diseases in St. Petersburg. Pharmateca. 2017; S5:56-59 (in Russ.).

17. Uspenskiy Y.P., Ivanov S.V. Population registers as a tool for practical health care and science. University Therapeutic Journal. 2020;2(1):76-77 (in Russ).

18. Uspenskiy Y.P., Shabrov A.V., Ivanov S.V., Fominykh Y.A., Shotik A.V. Basic therapy of inflammatory bowel diseases in St. Petersburg: results of a multicenter study. Experimental and clinical gastroenterology. 2022;198(2):64-76. https://doi.org/10.31146/1682-8658-ecg-198-2-64-76 (in Russ.).

19. Uspenskiy Y.P., Ivanov S.V., Fominikh Yu.A., Galagudza M.M. Features of inflammatory bowel diseases in St. Petersburg and peculiarities of basic therapy in the regional healthcare system: cross-sectional study results. Experimental and Clinical Gastroenterology. 2021;1(6):29-39. https://doi.org/10.31146/1682-8658-ecg-190-6-29-39 (In Russ.).

20. Zarubina T.V. Issues of information technologies implementation in health service. Vestnik Roszdravnadzora. 2018;3:20-25. (In Russ.).

21. Uspenskiy Y.P., Ivanov S.V., Fominykh Y.A., Grjibovski A.M. Prognosis of IBD - the risk of life-threatening complications. Certificate of registration of the computer program 2023613644, 17.02.2023. Application No. 2022683673 dated 02.12.2022 (In Russ.).

22. Uspenskiy Y.P., Ivanov S.V., Fominykh Y.A., Grjibovski A.M. Prognosis of IBD - the risk of urgent surgical complications. Certificate of registration of the computer program 2022684897, 19.12.2022. Application No. 2022683638 dated 02.12.2022 (In Russ.).